MYC and neoplasm: In this context, while MYC is considered a downstream effector of oncogenic Ras in PDAC, mediating its pleiotropic effects on tumor cell growth and metabolism [40,41], MYC can also substitute as a pivotal driver in the setting of “Ras independence”, and the resulting tumors tend to be highly aggressive and chemoresistant [42,43].